Variable Interest Entity

9 Months Ended

Jun. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Variable Interest Entity

Variable Interest EntityThe Company has substantial governance rights over Profarma Distribuidora de Produtos Farmacêuticos S.A. ("Profarma"), which allow it to direct the activities that significantly impact Profarma’s economic performance. As such, the Company consolidates the operating results of Profarma in its consolidated financial statements. The Company is not obligated to provide future financial support to Profarma.

The following assets and liabilities of Profarma are included in the Company's Consolidated Balance Sheets:

(in thousands)	June 30, 2020		September 30, 2019
Cash and cash equivalents	$	25,383	$	9,431
Accounts receivables, net	125,702		154,491
Inventories	138,477		185,602
Prepaid expenses and other	53,170		64,119
Property and equipment, net	23,806		30,961
Goodwill	82,309		82,309
Other intangible assets	74,598		74,429
Other long-term assets	53,004		9,169
Total assets	$	576,449	$	610,511
Accounts payable	$	119,012	$	165,053
Accrued expenses and other	34,043		49,191
Short-term debt	116,829		106,439
Long-term debt	47,119		60,973
Deferred income taxes	39,360		42,371
Other long-term liabilities	40,494		5,303
Total liabilities	$	396,857	$	429,330

        Profarma's assets can only be used to settle its obligations, and its creditors do not have recourse to the general credit of the Company.